Dose escalation and pharmacodynamic study of intravenous adminstration of Reolysin, a live replication competent RNA virus in patients with advanced solid tumors

被引：0
|
作者：
Ghalib, M. H.
Desai, K. K.
Gollamudi, R.
Chaudhary, I.
Einstein, M.
Coffey, M.
Mettinger, K.
Mani, S.
Goel, S.
机构：
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
[2] Oncolytics Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3583
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
    Anne M. Traynor
    Michael S. Gordon
    Dona Alberti
    David S. Mendelson
    Mark S. Munsey
    George Wilding
    Richard E. Gammans
    William L. Read
    Investigational New Drugs, 2010, 28 : 509 - 515
  • [32] Dose escalation and expansion cohort study for DS-8895a in patients with advanced solid tumors
    Satoh, Taroh
    Shitara, Kohei
    Iwasa, Satoru
    Yamaguchi, Kensei
    Muro, Kei
    Komatsu, Yoshito
    Nishina, Tomohiro
    Esaki, Taito
    Hasegawa, Jun
    Kakurai, Yasuyuki
    Kamiyama, Emi
    Nakata, Tomoko
    Nakamura, Kota
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [33] A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
    Traynor, Anne M.
    Gordon, Michael S.
    Alberti, Dona
    Mendelson, David S.
    Munsey, Mark S.
    Wilding, George
    Gammans, Richard E.
    Read, William L.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (04) : 509 - 515
  • [34] A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumors
    Kotsakis, A.
    Kouroussis, Ch.
    Androulakis, N.
    Agelaki, S.
    Kalbakis, K.
    Vamvakas, L.
    Vardakis, N.
    Kalykaki, A.
    Polyzos, A.
    Georgoulias, V.
    Mavroudis, D.
    ONCOLOGY, 2006, 71 (3-4) : 190 - 196
  • [35] A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors
    Amarantidis, Kyriakos
    Xenidis, Nikolaos
    Chelis, Leonidas
    Chiotis, Anestis
    Tentes, Apostolos
    Chatzaki, Ekaterini
    Kortsaris, Alexandros
    Polychronidis, A.
    Karakitsos, Petros
    Kakolyris, Stylianos
    ACTA ONCOLOGICA, 2010, 49 (02) : 245 - 251
  • [36] A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
    Sehdev, Amikar
    Karrison, Theodore
    Zha, Yuanyuan
    Janisch, Linda
    Turcich, Michelle
    Cohen, Ezra E. W.
    Maitland, Michael
    Polite, Blase N.
    Gajewski, Thomas F.
    Salgia, Ravi
    Pinto, Navin
    Bissonnette, Marc B.
    Fleming, Gini F.
    Ratain, Mark J.
    Sharma, Manish R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 309 - 317
  • [37] A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
    Amikar Sehdev
    Theodore Karrison
    Yuanyuan Zha
    Linda Janisch
    Michelle Turcich
    Ezra E. W. Cohen
    Michael Maitland
    Blase N. Polite
    Thomas F. Gajewski
    Ravi Salgia
    Navin Pinto
    Marc B. Bissonnette
    Gini F. Fleming
    Mark J. Ratain
    Manish R. Sharma
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 309 - 317
  • [38] Phase I dose escalation trial of pegzilarginase in patients with advanced solid tumors
    Rasco, Drew W.
    Eckhardt, S. Gail
    Davar, Diwakar
    Lewis, Karl
    Lara-Guerra, Humberto
    Alters, Susan E.
    Eckert, Stephen
    Rowlinson, Scott W.
    Wooldridge, James E.
    Carvajal, Richard D.
    CANCER RESEARCH, 2018, 78 (13)
  • [39] A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors
    Saridaki, Zacharenia
    Pappas, Periklis
    Souglakos, John
    Nikolaidou, Martha
    Vardakis, Nikolaos
    Kotsakis, Athanasios
    Marselos, Marios
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 121 - 128
  • [40] Phase I/Ib dose-escalation study of aveluma in Chinese patients with advanced solid tumors
    Wu, Yi-Long
    Cheng, Ying
    Chen, Huajun
    Tu, Haiyan
    Xu, Chongrui
    Wang, Zhen
    Liu, Ying
    Xin, Ying
    Lou, Haizhou
    Wang, Wei
    Chin, Kevin
    Li, Dandan
    Zhao, Di
    Gao, Yanfei
    Xu, Wenping
    Pan, Hongming
    FUTURE ONCOLOGY, 2022,
12345